[RCUS] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[RCUS] Arcus Biosciences, Inc.
Announcement Date
08-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -2.64%
YoY- -4,379.64%
Quarter Report
RCUS's Result
RCUS's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 26,759 18,005 354,499 9,461 9,461 9,461 9,487 100.01%
PBT -66,632 -66,989 281,183 -77,975 -75,970 -72,593 -51,853 18.25%
Tax -2,350 1,004 1,815 -100 -100 438 -1,820 18.63%
NP -64,282 -67,993 279,368 -77,975 -75,970 -72,593 -51,853 15.44%
Tax Rate - - -0.65% - - - - -
Total Cost 91,041 85,998 75,131 87,436 85,431 82,054 61,340 30.20%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -240.23 -377.63 78.81 -824.17 -802.98 -767.29 -546.57 -42.27%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.90 -0.96 3.97 -1.11 -1.09 -1.08 -0.82 6.42%
EPS Diluted -0.90 -0.96 3.71 -1.11 -1.09 -1.08 -0.82 6.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.